CompletedNot Applicable

Evaluation of Lactate in Patients Undergoing Glial and Non Glial Mass Surgery With Craniotomy

Turkey (Türkiye)100 participantsStarted 2019-12-10

Plain-language summary

The aim of this study is to determine the effects of the level of metabolites used in routine on mortality and morbidity in patients who will undergo intracranial surgery with craniotomy.

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion criteria

✓. Having an intracranial mass operation with craniotomy
✓. No history of congestive heart failure
✓. No kidney and liver dysfunction
✓. Not pregnant
✓. Not taking inotropic drugs during the operation
✓. Receiving less than four red blood product replacements during the operation

Exclusion criteria

✕. Patients with a history of congestive heart failure
✕. Patients with kidney and liver dysfunction
✕. Patients who need an inotropic agent to adjust blood pressure during the operation
✕. Patients who have undergone four or more red blood product transfusions during the operation
✕. Pregnant patients

What they're measuring

lactate level

Timeframe: change from operation to post-op second day (4 time)

Trial details

NCT IDNCT04584827

SponsorTrakya University

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2021-12-10

View on ClinicalTrials.gov More Lactate trials